Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination of 3-methyladenine therapy and Asn-Gly-Arg (NGR)-modified mesoporous silica nanoparticles loaded with temozolomide for glioma therapy in vitro
Peng Zhang, Menghuan Tang, Qin Huang, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 509, Iss. 2, pp. 549-556
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Biomedical polymers: synthesis, properties, and applications
Wei‐Hai Chen, Qi‐Wen Chen, Qian Chen, et al.
Science China Chemistry (2022) Vol. 65, Iss. 6, pp. 1010-1075
Open Access | Times Cited: 125
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
Raúl Ortíz, Gloria Perazzoli, Laura Cabeza, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 513-537
Open Access | Times Cited: 104
Polydopamine‐Based Nanoparticles for Photothermal Therapy/Chemotherapy and their Synergistic Therapy with Autophagy Inhibitor to Promote Antitumor Treatment
Jiahui Lü, Lulu Cai, Yue Dai, et al.
The Chemical Record (2021) Vol. 21, Iss. 4, pp. 781-796
Closed Access | Times Cited: 100
Molecular insights and novel approaches for targeting tumor metastasis
Sabya Sachi Das, Saad Alkahtani, Priyanshu Bharadwaj, et al.
International Journal of Pharmaceutics (2020) Vol. 585, pp. 119556-119556
Closed Access | Times Cited: 79
Autophagy as a Potential Therapy for Malignant Glioma
Ángel Escamilla-Ramírez, Rosa Angélica Castillo‐Rodríguez, Sergio Zavala-Vega, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 156-156
Open Access | Times Cited: 71
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
Menglu Zhu, Yi Shi, Yifan Shan, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 71
Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review
Arezoo Sodagar Taleghani, Ali Taghvaie Nakhjiri, Mohammad Javad Khakzad, et al.
Journal of Molecular Liquids (2021) Vol. 328, pp. 115417-115417
Closed Access | Times Cited: 54
Nanoscale Drug Delivery Systems in Glioblastoma
Zihao Liu, Xiaoshuai Ji, He Dong, et al.
Nanoscale Research Letters (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma
Taskeen Iqbal Janjua, Yuxue Cao, Aria Ahmed-Cox, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 161-174
Open Access | Times Cited: 37
Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment
Nerea Iturrioz-Rodríguez, Nicolás Samprón, Ander Matheu
Theranostics (2023) Vol. 13, Iss. 9, pp. 2734-2756
Open Access | Times Cited: 25
Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration
Rafael Miguel Sábio, Andréía Bagliotti Meneguin, Aline Martins dos Santos, et al.
Microporous and Mesoporous Materials (2020) Vol. 312, pp. 110774-110774
Closed Access | Times Cited: 58
Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles
Miguel Gisbert-Garzarán, Maria Vallet‐Regí
Nanomaterials (2020) Vol. 10, Iss. 5, pp. 916-916
Open Access | Times Cited: 54
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Leonardo Delello Di Filippo, Juliana H. Azambuja, Jessyca Aparecida Paes Dutra, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 168, pp. 76-89
Closed Access | Times Cited: 41
PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment
Hao Wu, Min Wei, Yu Xu, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3751-3775
Open Access | Times Cited: 33
Nanomedicine for glioblastoma: Progress and future prospects
Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 172-186
Closed Access | Times Cited: 28
Challenges and advances for glioma therapy based on inorganic nanoparticles
Die Hu, Miao Xia, Linxuan Wu, et al.
Materials Today Bio (2023) Vol. 20, pp. 100673-100673
Open Access | Times Cited: 16
Loco-regional treatment with temozolomide-loaded thermogels prevents glioblastoma recurrences in orthotopic human xenograft models
Lisa Gherardini, Veronica Vetri Buratti, Mirko Maturi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies
Nada Walweel, Ömer Aydın
ACS Omega (2024) Vol. 9, Iss. 26, pp. 27832-27852
Open Access | Times Cited: 5
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment
Agata M. Gaweł, Anna Bętkowska, Ewa Gajda, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1822-1822
Open Access | Times Cited: 5
NGR-poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate enhances the antitumor effect of quercetin liposomes in triple-negative breast cancer
Chengcheng Zhao, Jian Qin, Dingyu Zhang, et al.
Pharmaceutical Development and Technology (2025), pp. 1-19
Closed Access
Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles
Miguel Gisbert-Garzarán, Daniel Lozano, Maria Vallet‐Regí
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9696-9696
Open Access | Times Cited: 43
Nanoparticles modified with vasculature-homing peptides for targeted cancer therapy and angiogenesis imaging
Elham Seyyednia, Fatemeh Oroojalian, Behzad Baradaran, et al.
Journal of Controlled Release (2021) Vol. 338, pp. 367-393
Closed Access | Times Cited: 36
Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 494-513
Closed Access | Times Cited: 26
Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook
Mohammad Reza Sepand, Sheyda Ranjbar, Ivan M. Kempson, et al.
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 29, pp. 102243-102243
Closed Access | Times Cited: 33
Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs
S.Yu. Kovtareva, Lyazat Kusepova, Gaukhar Tazhkenova, et al.
Polymers (2024) Vol. 16, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top